{"id":"https://openalex.org/W2320175997","doi":"https://doi.org/10.1158/2326-6066.cir-14-0050","title":"Intravenous Injection of MVA Virus Targets CD8+ Lymphocytes to Tumors to Control Tumor Growth upon Combinatorial Treatment with a TLR9 Agonist","display_name":"Intravenous Injection of MVA Virus Targets CD8+ Lymphocytes to Tumors to Control Tumor Growth upon Combinatorial Treatment with a TLR9 Agonist","publication_year":2014,"publication_date":"2014-08-29","ids":{"openalex":"https://openalex.org/W2320175997","doi":"https://doi.org/10.1158/2326-6066.cir-14-0050","mag":"2320175997","pmid":"https://pubmed.ncbi.nlm.nih.gov/25168392"},"language":"en","primary_location":{"id":"doi:10.1158/2326-6066.cir-14-0050","doi":"https://doi.org/10.1158/2326-6066.cir-14-0050","is_oa":false,"landing_page_url":"https://doi.org/10.1158/2326-6066.cir-14-0050","pdf_url":null,"source":{"id":"https://openalex.org/S2765010658","display_name":"Cancer Immunology Research","issn_l":"2326-6066","issn":["2326-6066","2326-6074"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Immunology Research","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2320175997"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5112905987","display_name":"Laetitia Fend","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I152238723","display_name":"Transgene (France)","ror":"https://ror.org/02d4qpq05","country_code":"FR","type":"company","lineage":["https://openalex.org/I152238723"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Laetitia Fend","raw_affiliation_strings":["1Transgene S.A., Illkirch-Graffenstaden, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Transgene S.A., Illkirch-Graffenstaden, France","institution_ids":["https://openalex.org/I152238723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063042997","display_name":"Tanja Gatard-Scheikl","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I152238723","display_name":"Transgene (France)","ror":"https://ror.org/02d4qpq05","country_code":"FR","type":"company","lineage":["https://openalex.org/I152238723"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Tanja Gatard-Scheikl","raw_affiliation_strings":["1Transgene S.A., Illkirch-Graffenstaden, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Transgene S.A., Illkirch-Graffenstaden, France","institution_ids":["https://openalex.org/I152238723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001478143","display_name":"Jacqueline Kintz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I152238723","display_name":"Transgene (France)","ror":"https://ror.org/02d4qpq05","country_code":"FR","type":"company","lineage":["https://openalex.org/I152238723"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Jacqueline Kintz","raw_affiliation_strings":["1Transgene S.A., Illkirch-Graffenstaden, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Transgene S.A., Illkirch-Graffenstaden, France","institution_ids":["https://openalex.org/I152238723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046488964","display_name":"Murielle Gantzer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I152238723","display_name":"Transgene (France)","ror":"https://ror.org/02d4qpq05","country_code":"FR","type":"company","lineage":["https://openalex.org/I152238723"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Murielle Gantzer","raw_affiliation_strings":["1Transgene S.A., Illkirch-Graffenstaden, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Transgene S.A., Illkirch-Graffenstaden, France","institution_ids":["https://openalex.org/I152238723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044410090","display_name":"Emmanuelle Schaedler","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I152238723","display_name":"Transgene (France)","ror":"https://ror.org/02d4qpq05","country_code":"FR","type":"company","lineage":["https://openalex.org/I152238723"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Emmanuelle Schaedler","raw_affiliation_strings":["1Transgene S.A., Illkirch-Graffenstaden, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Transgene S.A., Illkirch-Graffenstaden, France","institution_ids":["https://openalex.org/I152238723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066332743","display_name":"Karola Rittner","orcid":"https://orcid.org/0000-0002-6301-7198","observed_orcids":["https://orcid.org/0000-0002-6301-7198"]},"institutions":[{"id":"https://openalex.org/I152238723","display_name":"Transgene (France)","ror":"https://ror.org/02d4qpq05","country_code":"FR","type":"company","lineage":["https://openalex.org/I152238723"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Karola Rittner","raw_affiliation_strings":["1Transgene S.A., Illkirch-Graffenstaden, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Transgene S.A., Illkirch-Graffenstaden, France","institution_ids":["https://openalex.org/I152238723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033732045","display_name":"Sandrine Cochin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I152238723","display_name":"Transgene (France)","ror":"https://ror.org/02d4qpq05","country_code":"FR","type":"company","lineage":["https://openalex.org/I152238723"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Sandrine Cochin","raw_affiliation_strings":["1Transgene S.A., Illkirch-Graffenstaden, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Transgene S.A., Illkirch-Graffenstaden, France","institution_ids":["https://openalex.org/I152238723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001030779","display_name":"Sylvie Fournel","orcid":"https://orcid.org/0000-0003-3583-6548","observed_orcids":["https://orcid.org/0000-0003-3583-6548"]},"institutions":[{"id":"https://openalex.org/I1294671590","display_name":"Centre National de la Recherche Scientifique","ror":"https://ror.org/02feahw73","country_code":"FR","type":"government","lineage":["https://openalex.org/I1294671590"]},{"id":"https://openalex.org/I4210093067","display_name":"Laboratoire de Ch\u00e9mo-biologie synth\u00e9tique et th\u00e9rapeutique","ror":"https://ror.org/00rh71z37","country_code":"FR","type":"facility","lineage":["https://openalex.org/I1294671590","https://openalex.org/I4210093067","https://openalex.org/I4210128300","https://openalex.org/I68947357"]},{"id":"https://openalex.org/I68947357","display_name":"Universit\u00e9 de Strasbourg","ror":"https://ror.org/00pg6eq24","country_code":"FR","type":"education","lineage":["https://openalex.org/I68947357"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Sylvie Fournel","raw_affiliation_strings":["2Laboratoire de Conception et Application de Mol\u00e9cules Bioactives, Equipe de Biovectorologie, UMR 7199 CNRS-Universit\u00e9 de Strasbourg, Facult\u00e9 de Pharmacie, Illkirch-Graffenstaden, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Laboratoire de Conception et Application de Mol\u00e9cules Bioactives, Equipe de Biovectorologie, UMR 7199 CNRS-Universit\u00e9 de Strasbourg, Facult\u00e9 de Pharmacie, Illkirch-Graffenstaden, France","institution_ids":["https://openalex.org/I1294671590","https://openalex.org/I4210093067","https://openalex.org/I68947357"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5071860529","display_name":"Xavier Pr\u00e9ville","orcid":"https://orcid.org/0000-0002-1416-7405","observed_orcids":["https://orcid.org/0000-0002-1416-7405"]},"institutions":[{"id":"https://openalex.org/I152238723","display_name":"Transgene (France)","ror":"https://ror.org/02d4qpq05","country_code":"FR","type":"company","lineage":["https://openalex.org/I152238723"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Xavier Pr\u00e9ville","raw_affiliation_strings":["1Transgene S.A., Illkirch-Graffenstaden, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Transgene S.A., Illkirch-Graffenstaden, France","institution_ids":["https://openalex.org/I152238723"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5071860529"],"corresponding_institution_ids":["https://openalex.org/I152238723"],"apc_list":null,"apc_paid":null,"fwci":0.7967,"has_fulltext":false,"cited_by_count":22,"citation_normalized_percentile":{"value":0.6777786,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"2","issue":"12","first_page":"1163","last_page":"1174"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.9887999892234802,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.9887999892234802,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.006599999964237213,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":0.00279999990016222,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mva-vaccine","display_name":"MVA vaccine","score":0.6169999837875366},{"id":"https://openalex.org/keywords/cd8-t-cells","display_name":"CD8+ T cells","score":0.8450000286102295},{"id":"https://openalex.org/keywords/muc1-antigen","display_name":"MUC1 antigen","score":0.800000011920929},{"id":"https://openalex.org/keywords/tlr9-agonist","display_name":"TLR9 agonist","score":0.8629999756813049},{"id":"https://openalex.org/keywords/renal-carcinoma","display_name":"renal carcinoma","score":0.824999988079071},{"id":"https://openalex.org/keywords/orthotopic-tumor-model","display_name":"orthotopic tumor model","score":0.8489999771118164},{"id":"https://openalex.org/keywords/pd-1","display_name":"PD-1","score":0.8289999961853027},{"id":"https://openalex.org/keywords/tim-3","display_name":"TIM-3","score":0.8320000171661377},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.7229999899864197},{"id":"https://openalex.org/keywords/th1-response","display_name":"Th1 response","score":0.8650000095367432},{"id":"https://openalex.org/keywords/t-cell-infiltration","display_name":"T cell infiltration","score":0.34200000762939453},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.6430000066757202}],"concepts":[{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.7128843665122986},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.579391598701477},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.5769000053405762},{"id":"https://openalex.org/C2779138994","wikidata":"https://www.wikidata.org/wiki/Q15332550","display_name":"TLR9","level":5,"score":0.5486822128295898},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4930681884288788},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.47696030139923096},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.4454376697540283},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.43255022168159485},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.4297633171081543},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.41402214765548706},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.39537787437438965},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3233548700809479},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2946040630340576},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2407822608947754},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.24007219076156616},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.1844915747642517},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.17740511894226074},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C190727270","wikidata":"https://www.wikidata.org/wiki/Q874745","display_name":"DNA methylation","level":4,"score":0.0},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005822","descriptor_name":"Genetic Vectors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005822","descriptor_name":"Genetic Vectors","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007275","descriptor_name":"Injections, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D009841","descriptor_name":"Oligonucleotides","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D009841","descriptor_name":"Oligonucleotides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D010641","descriptor_name":"Phenotype","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014018","descriptor_name":"Tissue Distribution","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014616","descriptor_name":"Vaccinia virus","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D015870","descriptor_name":"Gene Expression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016130","descriptor_name":"Immunophenotyping","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016246","descriptor_name":"Lymphocytes, Tumor-Infiltrating","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D016246","descriptor_name":"Lymphocytes, Tumor-Infiltrating","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D018396","descriptor_name":"Mucin-1","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D018396","descriptor_name":"Mucin-1","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D018414","descriptor_name":"CD8-Positive T-Lymphocytes","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D018414","descriptor_name":"CD8-Positive T-Lymphocytes","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D019496","descriptor_name":"Cancer Vaccines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D019496","descriptor_name":"Cancer Vaccines","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D019496","descriptor_name":"Cancer Vaccines","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D020869","descriptor_name":"Gene Expression Profiling","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D047368","descriptor_name":"Tumor Burden","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D047368","descriptor_name":"Tumor Burden","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D051217","descriptor_name":"Toll-Like Receptor 9","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1158/2326-6066.cir-14-0050","doi":"https://doi.org/10.1158/2326-6066.cir-14-0050","is_oa":false,"landing_page_url":"https://doi.org/10.1158/2326-6066.cir-14-0050","pdf_url":null,"source":{"id":"https://openalex.org/S2765010658","display_name":"Cancer Immunology Research","issn_l":"2326-6066","issn":["2326-6066","2326-6074"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Immunology Research","raw_type":"journal-article"},{"id":"pmid:25168392","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25168392","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer immunology research","raw_type":"Journal Article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.849.5926","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.849.5926","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://cancerimmunolres.aacrjournals.org/content/2/12/1163.full.pdf","raw_type":"text"},{"id":"pmh:oai:HAL:hal-05028362v1","doi":null,"is_oa":false,"landing_page_url":"https://hal.science/hal-05028362","pdf_url":null,"source":{"id":"https://openalex.org/S4306402512","display_name":"HAL","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4405252976","host_organization_name":"Centre pour la Communication Scientifique Directe","host_organization_lineage":["https://openalex.org/I4405252976"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Cancer Immunology Research, 2014, 2 (12), pp.1163-1174. ⟨10.1158/2326-6066.cir-14-0050⟩","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":51,"referenced_works":["https://openalex.org/W1482788763","https://openalex.org/W1499206957","https://openalex.org/W1625007357","https://openalex.org/W1769686661","https://openalex.org/W1966107523","https://openalex.org/W1966481035","https://openalex.org/W1967647128","https://openalex.org/W1981281783","https://openalex.org/W1986986419","https://openalex.org/W1992699637","https://openalex.org/W1993442154","https://openalex.org/W1994048581","https://openalex.org/W1994108614","https://openalex.org/W1994993231","https://openalex.org/W1998424883","https://openalex.org/W1999804339","https://openalex.org/W2004239490","https://openalex.org/W2011868039","https://openalex.org/W2012816646","https://openalex.org/W2022990363","https://openalex.org/W2023268216","https://openalex.org/W2023896765","https://openalex.org/W2039261563","https://openalex.org/W2042617819","https://openalex.org/W2051074253","https://openalex.org/W2051940924","https://openalex.org/W2057968053","https://openalex.org/W2066671159","https://openalex.org/W2079732145","https://openalex.org/W2079936875","https://openalex.org/W2083670478","https://openalex.org/W2088599017","https://openalex.org/W2089220120","https://openalex.org/W2093059993","https://openalex.org/W2100051740","https://openalex.org/W2102154168","https://openalex.org/W2104454069","https://openalex.org/W2105459360","https://openalex.org/W2129407204","https://openalex.org/W2130423245","https://openalex.org/W2135670128","https://openalex.org/W2137103099","https://openalex.org/W2140432305","https://openalex.org/W2142300779","https://openalex.org/W2148605435","https://openalex.org/W2157215695","https://openalex.org/W2163264180","https://openalex.org/W2164773905","https://openalex.org/W2167973689","https://openalex.org/W2172076789","https://openalex.org/W6681864317"],"related_works":["https://openalex.org/W2037064755","https://openalex.org/W2333434844","https://openalex.org/W2562954116","https://openalex.org/W2912868925","https://openalex.org/W4365511765","https://openalex.org/W3128608697","https://openalex.org/W3210001455","https://openalex.org/W4366185789","https://openalex.org/W3156959074"],"abstract_inverted_index":{"Effector":[0],"T-cell":[1],"access":[2],"to":[3,46,57,160],"tumor":[4,20,28,128,199],"tissue":[5],"is":[6,29],"a":[7,24,68,110,163,195,202],"limiting":[8],"step":[9],"for":[10,41],"clinical":[11,215],"efficacy":[12,66,93,100,191],"of":[13,61,67,89,101,109,117,127,166,197,208,217],"antigen-specific":[14],"T":[15,44,169],"cell-based":[16],"immunotherapies.":[17],"Ectopic":[18],"mouse":[19],"models,":[21],"in":[22,142,146,148,162],"which":[23],"subcutaneously":[25],"(s.c.)":[26],"implanted":[27],"treated":[30],"with":[31,96,125,153,194],"s.c.":[32,97,156],"or":[33],"intramuscular":[34],"therapeutic":[35,65],"immunization,":[36],"may":[37],"not":[38],"be":[39],"optimal":[40],"targeting":[42],"effector":[43,179],"cells":[45],"an":[47,52,178],"organ-borne":[48],"tumor.":[49],"We":[50,83],"used":[51],"orthotopic":[53],"renal":[54],"carcinoma":[55],"model":[56],"evaluate":[58],"the":[59,76,198,214,221],"impact":[60],"injection":[62,108],"routes":[63],"on":[64],"Modified":[69],"Vaccinia":[70],"virus":[71],"Ankara":[72],"viral":[73],"vector":[74],"expressing":[75],"human":[77],"mucin":[78],"1":[79],"tumor-associated":[80],"xeno-antigen":[81],"(MVA-MUC1).":[82],"show":[84],"that":[85],"intravenous":[86],"(i.v.)":[87],"administration":[88],"MVA-MUC1":[90,102],"displayed":[91],"enhanced":[92,105],"when":[94],"compared":[95,152],"injection.":[98,157],"Therapeutic":[99,190],"was":[103,123,192],"further":[104],"by":[106,120,177],"i.v.":[107,135,222],"TLR9":[111],"agonist.":[112],"In":[113],"all":[114],"cases,":[115],"infiltration":[116],"tumor-bearing":[118,173],"kidney":[119],"CD8(+)":[121,168],"lymphocytes":[122],"associated":[124,193],"control":[126],"growth.":[129],"Biodistribution":[130],"experiments":[131],"indicate":[132],"that,":[133],"following":[134,155],"injection,":[136],"MVA-encoded":[137],"antigens":[138],"are":[139,175],"quickly":[140],"expressed":[141],"visceral":[143],"organs":[144],"and,":[145],"particular,":[147],"splenic":[149],"antigen-presenting":[150],"cells,":[151],"those":[154],"This":[158,211],"appears":[159],"result":[161],"faster":[164],"generation":[165],"MUC1-specific":[167],"cells.":[170],"Lymphocytes":[171],"infiltrating":[172],"kidneys":[174],"characterized":[176],"memory":[180],"phenotype":[181],"and":[182,185,206],"express":[183],"PD-1":[184],"Tim3":[186],"immune":[187,204],"checkpoint":[188],"molecules.":[189],"modification":[196],"microenvironment":[200],"toward":[201],"Th1-type":[203],"response":[205],"recruitment":[207],"activated":[209],"lymphocytes.":[210],"study":[212],"supports":[213],"evaluation":[216],"MVA-based":[218],"immunotherapies":[219],"via":[220],"route.":[223]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":6},{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":1}],"updated_date":"2026-11-14T11:04:58.165337","created_date":"2016-06-24T00:00:00"}